The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s house dust mite allergy market report forecasts the house dust mite allergy market size to grow to $3.13 Billion by 2027, with a CAGR (compound annual growth rate) of more than 13%.

Learn More On The House Dust Mite Allergy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report

House Dust Mite Allergy Market Size Forecast
The global house dust mite allergy market is expected to grow from $1.44 billion in 2022 to $1.65 billion in 2023 at a compound annual growth rate (CAGR) of 14.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global house dust mite allergy market size is expected to reach $3.13 billion in 2027 at a CAGR of 13.5%.

North America held the largest house dust mite allergy market share, and Asia-pacific was the fastest-growing region in 2022.

Key House Dust Mite Allergy Market Driver ­– Increase In The Prevalence Of Asthma Diseases
According to the London School of Hygiene and Tropical Medicine, an English-based public university, the prevalence of asthma grew by more than 2% in Africa and 1% per 10 years in Europe in October 2021. Furthermore, according to the Centres for Disease Control and Prevention, a US-based national public health institution, the US asthma prevalence rate in 2020 was 7.8 percent, with 5.8 percent of children under the age of 18 suffering from the disease. Furthermore, the number of asthma-related emergency room visits in the United States was 1.2 million in 2020. As a result, the incidence of asthma disorders is pushing the market for house dust mite allergies.

Request for A Sample Of The Global House Dust Mite Allergy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9304&type=smp

Key House Dust Mite Allergy Market Trend – Product Innovations
To increase their market position, major businesses in the house dust mite allergy market are focusing on developing innovative products. For example, Alcon, a Swiss-based medical business specialising in eye care products and anti-allergic medications, will develop Pataday, a doctor-prescribed eye allergy itch reliever, in July 2020. It is specially formulated with olopatadine hydrochloride ophthalmic solution 0.2% and olopatadine hydrochloride ophthalmic solution 0.1%, both of which have been approved by the Food and Drug Administration, a US-based department of health, as the first and only allergy itch drop for the eye, providing over-the-counter eye allergy itch relief that lasts for the entire 24 hours.

House Dust Mite Allergy Market Segment
1) By Product Type: Tablets, Nasal Drops, Injectable
2) By Treatment Type: Medication, Immunotherapy, Nasal Irrigation, Other Types
3) By Diagnosis: Skin Prick Test (SPT), Specific Immunoglobulin E (IgE) Blood Test, Other Diagnosis
4) By Dosage Forms: Solid, Liquid
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

House Dust Mite Allergy Market Major Players and Strategies
Major players in the house dust mite allergy market are Allergy Therapeutics Plc., Bayer AG, Catalent Inc., GSK Plc., Merz Pharma GmbH & Co KGaA, Sanofi S A., Shionogi & Co Ltd., Stallergenes Greer International AG, Merck & Co Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC., DMS Group, HAL Allergy Group, Trio Lifescience Private Limited and Teva Pharmaceutical Industries Ltd.

Dermapharm Holding SE, a German-based major developer of patent-free medications, paid an unknown sum to buy Allergopharma GmbH & Co. KG in February 2020. The combined resources of Dermapharm and Allergopharma are expected to extend and strengthen Dermapharm’s international footprint and portfolio for allergy-specific immunotherapy. Allergopharma GmbH & Co. KG is a German firm that specialises in allergy desensitisation treatments.

The House Dust Mite Allergy Global Market Report 2023 covers regional data on house dust mite allergy market size, house dust mite allergy market trends and drivers, opportunities, strategies, and house dust mite allergy market competitor analysis. The countries covered in the house dust mite allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

House dust mite allergy is an allergic reaction to tiny insects commonly found in household dust. This covers treatment for allergic symptoms like sneezing as well as allergy-related diseases.

View More Reports Related To The House Dust Mite Allergy Market –
Household Laundry Equipment Global Market Report 2023
Allergy Conjunctivitis Global Market Report 2023
Allergy Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: